Pantoprazole

# Pantoprazole ## Overview - **Classification**: Proton Pump Inhibitor (PPI) - **Mechanism**: Irreversibly inhibits H+/K+-ATPase (proton pump) in gastric parietal cells, blocking acid secretion. ## Primary Indications 1. **Erosive Esophagitis (EE)** - Healing and maintenance of healing associated with GERD. 2. **Gastroesophageal Reflux Disease (GERD)** - Symptomatic relief of heartburn and acid regurgitation. 3. **Zollinger-Ellison Syndrome (ZES)** - Long-term treatment of pathological hypersecretory conditions. ## Adult Dosing ### Standard Dosing **Erosive Esophagitis (EE) / GERD** - **Dose**: **40 mg** - **Frequency**: Once daily - **Route**: Oral (Delayed-Release Tablet/Suspension) or Intravenous (IV) - **Duration**: Up to 8 weeks for healing; maintenance **20-40 mg** daily. **Zollinger-Ellison Syndrome (ZES)** - **Dose**: **40 mg** - **Frequency**: Twice daily (BID) initially, adjust per response. - **Route**: Oral or Intravenous - **Maximum dose**: Up to **240 mg** daily (divided doses) for ZES. ### Dose Adjustments - **Renal Impairment**: No dose adjustment typically needed. - **Hepatic Impairment**: - Mild to moderate: No adjustment. - Severe impairment (Child-Pugh C): Max **20 mg** daily. Avoid IV if severe. - **Elderly Patients**: No specific dose adjustment needed. Use lowest effective dose. ## Pediatric Dosing ### Neonates (0-28 days) - **Special Notes**: Not recommended. Safety and efficacy not established. Potential for serious adverse effects. ### Infants (1-12 months) - **Special Notes**: Limited data, generally considered off-label use for this age group. - **Dose (off-label)**: **0.6-1.2 mg/kg** - **Frequency**: Once daily - **Maximum**: Not well-established; typically **10 mg** daily if used. ### Children (1-12 years) - **Erosive Esophagitis (EE) / GERD (1-5 years)** - **Dose**: **10 mg** - **Frequency**: Once daily - **Maximum**: **10 mg** daily - **Erosive Esophagitis (EE) / GERD (6-11 years)** - **Dose**: **20 mg** - **Frequency**: Once daily - **Maximum**: **20 mg** daily ### Adolescents (13-18 years) - **Erosive Esophagitis (EE) / GERD** - **Dose**: **20-40 mg** - **Frequency**: Once daily - **Maximum**: **40 mg** daily (typically adult dose applies) ## Safety Information ### Contraindications - **Absolute**: Known hypersensitivity to pantoprazole or other substituted benzimidazoles. - **Absolute**: Concomitant use with rilpivirine-containing products. ### Common Adverse Effects - **Common (1-10%)**: Headache, diarrhea, nausea, abdominal pain, flatulence. - **Serious but Rare**: *Clostridioides difficile* associated diarrhea (CDAD), acute interstitial nephritis, bone fracture (long-term use), hypomagnesemia (long-term use), vitamin B12 deficiency (long-term use), cutaneous/systemic lupus erythematosus. ### Key Drug Interactions - **Clopidogrel**: May reduce antiplatelet effect. Avoid concurrent use if possible; consider alternative PPI or H2RA. - **HIV Antivirals (e.g., Atazanavir, Nelfinavir, Rilpivirine)**: Decreased absorption due to increased gastric pH. Contraindicated with rilpivirine. - **Methotrexate**: May increase and prolong methotrexate and/or its metabolite serum levels. Monitor for toxicity. - **Warfarin**: Increased INR and prothrombin time reported. Monitor closely when co-administered. ## Monitoring & Follow-up - **Before Treatment**: Baseline symptoms. - **During Treatment**: - Symptom improvement. - Long-term use (>3 months): Monitor serum magnesium levels. - Long-term use (>1 year): Consider monitoring vitamin B12 levels. - **Clinical Signs**: Watch for signs of CDAD (severe diarrhea, abdominal pain), hypomagnesemia (tetany, arrhythmias), B12 deficiency (fatigue, neuropathy). ## Clinical Pearls - 💡 **Timing**: Administer **30-60 minutes before the first meal** of the day for best efficacy. - 💡 **Administration**: Do not crush, chew, or split delayed-release tablets or granules. - 💡 **Long-term Use**: Avoid long-term use unless clearly indicated due to potential risks (fractures, hypomagnesemia, B12 deficiency, CDAD). - 💡 **Counseling**: Advise patients to report any unusual diarrhea, muscle spasms, or signs of fatigue. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.